A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours
Khan OA. et al, (2011), British Journal of Cancer
A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors
Leijen S. et al, (2011), Cancer Chemotherapy and Pharmacology, 1 - 10
CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.
Ait-Tahar K. et al, (2011), Haematologica, 96, 78 - 86
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
Khan OA. et al, (2011), Br J Cancer, 104, 1822 - 1827
Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.
Cooper CDO. et al, (2011), PLoS One, 6
Molecular targets in ovarian cancer
Agarwal R. and Blagden S., (2011), Cancer and Chemotherapy Reviews, 6, 37 - 44
Mutation and Protein Expression Biomarkers Correlate with Response to AKT Inhibition in a Phase I Trial of the Oral Pan AKT Inhibitor GSK2141795 (GSK795) in Patients (pts) with Platinum Resistant Ovarian Cancer
Gungor H. et al, (2011), EUROPEAN JOURNAL OF CANCER, 47, 12 - 13
Pharmacokinetic (PK)/pharmacodynamic (PD) analysis of escalating repeat doses of the AKT inhibitor GSK2141795 (GSK795) in patients (pts) with ovarian cancer.
Gungor H. et al, (2011), JOURNAL OF CLINICAL ONCOLOGY, 29
Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
Gillies RS. et al, (2011), British Journal of Surgery
Angiogenesis - still a worthwhile target for breast cancer therapy?
Lord S. and Harris AL., (2010), Breast Cancer Res, 12 Suppl 4
Co Existence of LMPP Like and GMP Like Leukemia Stem Cells In Acute Myeloid Leukemia
Goardon N. et al, (2010), BLOOD, 116, 46 - 46
Co Existence of LMPP Like and GMP Like Leukemia Stem Cells In Acute Myeloid Leukemia
Goardon N. et al, (2010), BLOOD, 116, 46 - 46
Co-Existence of LMPP-Like and GMP-Like Leukemia Stem Cells In Acute Myeloid Leukemia
Goardon N. et al, (2010), BLOOD, 116, 46 - 46
Platelet Function and Response to Thrombopoietin Mimetics In Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia
Bussel JB. et al, (2010), BLOOD, 116, 613 - 614
The Effect of Eltrombopag on Human Platelet Resistance to Apoptosis: The Role of the Bcl-Xl Pathway.
Mitchell WB. et al, (2010), BLOOD, 116, 1044 - 1044
HEALTH-CARE RESOURCE UTILIZATION IN ADVANCED MELANOMA: AN ANALYSIS FROM THE MELODY OBSERVATIONAL STUDY
Lorigan P. et al, (2010), VALUE IN HEALTH, 13, A272 - A272
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A.
De Santo C. et al, (2010), Nat Immunol, 11, 1039 - 1046
Thyrotoxicosis with pegylated interferon alfa-2b.
Lowndes SA. et al, (2010), Arch Dermatol, 146, 1273 - 1275
A phase 2 study of vatalanib in metastatic melanoma patients.
Cook N. et al, (2010), Eur J Cancer, 46, 2671 - 2673
A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer.
Sabharwal A. et al, (2010), Cancer Chemother Pharmacol, 66, 829 - 835